An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human ...
Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...
Researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it to support its survival and replication. The 'loophole' is a biological ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
The Access Framework outlines how, by 2030, countries can ensure that 90% of people in need of prevention services have ...
Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...
For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
Advanced therapies are not linked to increased risk for serious or opportunistic infections, cancer, operations, or mortality ...
Sunlenca (lenacapavir) is a medicine that was approved by the FDA in 2022 to treat HIV in combination with other HIV medicines. Sunlenca has a unique mechanism of action and is the first medicine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results